LYNK SOLUTEC Secures Funding for Medical Device Coating

LYNK SOLUTEC, a startup specializing in medical device surface coating, has secured a 1.5 billion KRW (approximately 1.2 million USD) pre-Series A funding. This round saw participation from POSTECH Holdings and Korea Technology Finance Corporation.

Understanding LYNK SOLUTEC’s Innovative Technology

LYNK SOLUTEC has developed a non-stick nano-film coating technology aimed at reducing complications like infections, inflammation, and thrombosis in implantable medical devices. This technology blocks protein, immune cells, and bacteria from attaching to the device surface, maintaining stable performance even after implantation.

Key Features of the Technology

The coating technology of LYNK SOLUTEC is noted for:

Application to various medical devices such as endoscopes, stents, catheters, and silicone tubes.
An easy application process compared to existing products.
Significant efficacy in maintaining performance over time.

Achievements and Industry Recognition

Their product was recognized at CES 2024, winning awards in both ‘Human Security’ and ‘Digital Health’ categories.

Partnerships and Developments

LYNK SOLUTEC stemmed from Yonsei University’s Biointerface and Sensor System Lab. They engage in multiple collaborative research and commercialization projects with hospitals and medical device companies. Current efforts include:

Expanding their portfolio starting with Class 1 endoscope accessories.
Developing ophthalmic and urology equipment.
Seeking FDA approvals for the US market and partners for Middle East expansion.

Recent Product Launch: Clean View

In February, LYNK SOLUTEC launched ‘Clean View’, a coating solution preventing fogging and bio-material adhesion on endoscope lenses.

Future Plans with New Funding

The recent fundraise will expedite:

Mass production and sales of endoscope coatings.
Diversification of their product portfolio.
Expansion of global regulatory strategies.

Here’s what else is happening in the sector:

OmniCoat, a company specializing in dry laser printing on metal surfaces, is expanding into the dry electrode field for secondary batteries.
Dentiple has secured seed funding from Series Ventures for its dental implant manufacturing.
Celoid received 2.4 billion KRW for its 3D cell culture technology in a pre-Series A round.
Hydro Expand is developing water electrolysis stacks, now supported by pre-series A investment.

Follow these tags for more updates: